Doseology Sciences Inc. (DOSEF)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 1.39 Million CAD | -63.85% |
| 2021 | 3.86 Million CAD | -35.41% |
| 2020 | 5.99 Million CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | 1.17 Million CAD | -11.37% |
| 2023 Q1 | 1.32 Million CAD | -5.12% |
| 2022 FY | 1.39 Million CAD | -63.85% |
| 2022 Q4 | 1.39 Million CAD | -51.56% |
| 2022 Q3 | 2.88 Million CAD | -6.82% |
| 2022 Q2 | 3.09 Million CAD | -5.64% |
| 2022 Q1 | 3.28 Million CAD | -15.12% |
| 2021 Q1 | 5.36 Million CAD | -10.41% |
| 2021 FY | 3.86 Million CAD | -35.41% |
| 2021 Q4 | 3.86 Million CAD | -12.86% |
| 2021 Q3 | 4.44 Million CAD | -10.74% |
| 2021 Q2 | 4.97 Million CAD | -7.3% |
| 2020 Q4 | 5.99 Million CAD | 0.0% |
| 2020 FY | 5.99 Million CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 96.399% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | 80.625% |
| SQZ Biotechnologies Company | 107.18 Million USD | 98.695% |
| Evofem Biosciences, Inc. | 10.55 Million USD | 86.746% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 98.926% |
| Mesoblast Limited | 667.9 Million USD | 99.791% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -1833.042% |
| Genus plc | 1.02 Billion USD | 99.864% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -2.981% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -180.308% |
| Marizyme, Inc. | 22.01 Million USD | 93.646% |
| ContraFect Corporation | 20.67 Million USD | 93.235% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -123.101% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -258.342% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -266.02% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | 2.317% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | 66.261% |
| MultiCell Technologies, Inc. | 126.22 USD | -1108160.181% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -48.863% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 98.911% |
| EV Biologics, Inc. | 431.71 Thousand USD | -224.021% |
| Q BioMed Inc. | 3.51 Million USD | 60.209% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 96.024% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -81.516% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -435.388% |
| Biomind Labs Inc. | 73.81 Thousand USD | -1794.967% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 462.85 Million USD | 99.698% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 95.34% |
| Skye Bioscience, Inc. | 11.94 Million USD | 88.285% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | 57.777% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | 49.065% |
| Arch Therapeutics, Inc. | 1.95 Million USD | 28.564% |
| IMV Inc. | 31.33 Million USD | 95.536% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -103.473% |
| Curative Biotechnology, Inc. | 2.6 Million USD | 46.264% |
| GB Sciences, Inc. | 103.44 Thousand USD | -1252.3% |
| Alpha Cognition Inc. | 2.45 Million USD | 42.955% |
| HST Global, Inc. | 1526.00 USD | -91567.497% |
| CSL Limited | 38.02 Billion USD | 99.996% |
| Halberd Corporation | 10.13 Thousand USD | -13707.581% |
| Enzolytics Inc. | 361.7 Million USD | 99.613% |
| Resverlogix Corp. | 8.11 Million USD | 82.762% |
| Affymax, Inc. | 7.44 Million USD | 81.206% |
| SYBLEU INC | 330.46 Thousand USD | -323.292% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | 25.509% |
| argenx SE | 4.54 Billion USD | 99.969% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 94.994% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 97.068% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -6040.406% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | 84.369% |
| AVAX Technologies, Inc. | 7.37 Million USD | 81.038% |
| Zenith Capital Corp. | 7410.00 USD | -18777.814% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.959% |
| Ember Therapeutics, Inc. | 184.00 USD | -760142.391% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -334.686% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -435.21% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 99.687% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | 3.451% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 3.02 Million USD | 53.758% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 97.346% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -50.744% |
| BioStem Technologies, Inc. | 14.56 Million USD | 90.393% |
| ONE Bio Corp. | 70.08 Million USD | 98.004% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -2350.075% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -60456.104% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -41.588% |
| Agentix Corp. | 261.39 Thousand USD | -435.153% |
| LadRx Corporation | 2.3 Million USD | 39.388% |
| Cell Source, Inc. | 195.17 Thousand USD | -616.728% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -191.088% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -295.582% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -295.582% |
| NovAccess Global Inc. | 62.24 Thousand USD | -2147.214% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -118.687% |
| Itoco Inc. | 1.4 Million USD | 0.088% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -1362.356% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -1219.666% |
| Kadimastem Ltd | 2.3 Million USD | 39.288% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -1732.053% |
| CytoDyn Inc. | 11.13 Million USD | 87.439% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -878.406% |
| Mobile Lads Corp. | 52.00 USD | -2689988.462% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -7723.523% |
| Qrons Inc. | 420.00 USD | -332958.571% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -262.893% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -153.359% |
| Rebus Holdings, Inc. | 5000.00 USD | -27876.92% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -241.664% |
| International Stem Cell Corporation | 5.39 Million USD | 74.047% |
| Bioxytran, Inc. | 137.63 Thousand USD | -916.323% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 90.675% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 91.563% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -1670.691% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -61.777% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | 81.391% |
| Neutra Corp. | 2851.00 USD | -48965.1% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 95.683% |
| PureTech Health plc | 693.97 Million USD | 99.798% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | 82.668% |
| IXICO plc | 15.84 Million USD | 91.171% |
| IntelGenx Technologies Corp. | 8.28 Million USD | 83.11% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 98.646% |
| CSL Limited | 38.02 Billion USD | 99.996% |
| Cellectis S.A. | 333.99 Million USD | 99.581% |